PMID- 22441042 OWN - NLM STAT- MEDLINE DCOM- 20120921 LR - 20121115 IS - 1873-7544 (Electronic) IS - 0306-4522 (Linking) VI - 210 DP - 2012 May 17 TI - Smilagenin attenuates beta amyloid (25-35)-induced degeneration of neuronal cells via stimulating the gene expression of brain-derived neurotrophic factor. PG - 275-85 LID - 10.1016/j.neuroscience.2012.03.017 [doi] AB - The development of drugs that attenuate neurodegeneration is important for the treatment of Alzheimer's disease (AD). We previously found that smilagenin (SMI), a steroidal sapogenin from traditional Chinese medicinal herbs improves memory in animal models, is neither a cholinesterase inhibitor nor a glutamate receptor antagonist, but can significantly elevate the declined muscarinic receptor (M receptor) density. In this article, to clarify whether SMI represents a new approach for treating neurodegeneration disease, we first demonstrate that SMI pretreatment significantly attenuates the neurodegenerative changes induced by beta amyloid 25-35 (Abeta(25-35)) in cultured rat cortical neurons, including decreased cholinergic neuron number, shortened neurite outgrowth length, and declined M receptor density. Brain-derived neurotrophic factor (BDNF) protein levels in the culture medium were also decreased by Abeta(25-35) and significantly elevated by SMI. Parallel experiments revealed that when the trk receptors were inhibited by K252a or the action of BDNF was inhibited by a neutralizing anti-BDNF antibody, the effects of SMI on the Abeta(25-35)-induced neurodegeneration in rat cortical neurons were almost completely abolished. In the all-trans retinoic acid (RA)-differentiated SH-SY5Y neuroblastoma cells, the BDNF transcription rate measured by a nuclear run-on assay was significantly suppressed by Abeta(25-35) and elevated by SMI, but the BDNF degradation rate measured by half-life determination was unchanged by Abeta(25-35) and SMI. Transcript analysis of the SH-SY5Y cells using quantitative RT-PCR (qRT-PCR) showed that the IV and VI transcripts of BDNF mRNA were significantly decreased by Abeta(25-35) and elevated by SMI. Taken together, we conclude that SMI attenuates Abeta(25-35)-induced neurodegeneration in cultured rat cortical neurons and SH-SY5Y cells mainly through stimulating BDNF mRNA transcription implicating that SMI may represent a novel therapeutic strategy for AD. CI - Copyright (c) 2012 IBRO. All rights reserved. FAU - Zhang, R AU - Zhang R AD - Research Laboratory of Cell Regulation, Shanghai Jiaotong University School of Medicine, 280 South Chongqing Road, Shanghai 200025, China. FAU - Wang, Z AU - Wang Z FAU - Howson, P A AU - Howson PA FAU - Xia, Z AU - Xia Z FAU - Zhou, S AU - Zhou S FAU - Wu, E AU - Wu E FAU - Xia, Z AU - Xia Z FAU - Hu, Y AU - Hu Y LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120313 PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Amyloid beta-Peptides) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Spirostans) RN - CFS802C28F (sarsasapogenin) SB - IM MH - Amyloid beta-Peptides/*toxicity MH - Animals MH - Brain-Derived Neurotrophic Factor/*biosynthesis MH - Cell Line MH - Gene Expression/drug effects MH - Humans MH - Nerve Degeneration/*metabolism MH - Neurons/*drug effects/metabolism MH - Rats MH - Real-Time Polymerase Chain Reaction MH - Reverse Transcriptase Polymerase Chain Reaction MH - Spirostans/*pharmacology EDAT- 2012/03/24 06:00 MHDA- 2012/09/22 06:00 CRDT- 2012/03/24 06:00 PHST- 2012/03/02 00:00 [received] PHST- 2012/03/06 00:00 [accepted] PHST- 2012/03/24 06:00 [entrez] PHST- 2012/03/24 06:00 [pubmed] PHST- 2012/09/22 06:00 [medline] AID - S0306-4522(12)00229-1 [pii] AID - 10.1016/j.neuroscience.2012.03.017 [doi] PST - ppublish SO - Neuroscience. 2012 May 17;210:275-85. doi: 10.1016/j.neuroscience.2012.03.017. Epub 2012 Mar 13.